18.04.2011 • News

Louis Neltner Appointed Rhodia Vice President, Research & Development

Rhodia has apponted Louis Neltner as vice president, Research & Development. He will be a member of the group's management committee.

Alumnus of the Ecole Normale Supérieure, Louis Neltner, holds a PhD in Physics and is an engineer from France's Corps des Mines. He started his career in the public sector in 1999, at the French Telecommunications Regulatory Authority (ART), then moved to the general Inspectorate of Finance. Manager at McKinsey since 2004, he directed complex strategy-related projects and transformation programs for large companies in industry and high-tech sectors.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

Top-Feature

most read

Photo
News • Chemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.